Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2021 and 2022.
-
Annual account missing NBB
Fiscal year 2023 was expected before 31 July 2024 and has not been filed.
Financials
Financial year 2022
Geneeskunde voor het Volk-Genk from Genk, company number BE0418710990, closed financial year 2022 with a result of € -161,909 after tax. For that financial year Geneeskunde voor het Volk-Genk recorded a gross margin of € 831,705 and equity of € 556,285. Compared with financial year 2021, the result moved from € -320,490 to € -161,909. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2023.
€ 556,285
▼ 23% vs 2021
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -161,909
▲ 49 % less loss than in 2021
Profit after tax over the fiscal year.
€ 368,715
▼ 26% vs 2021
Cash and bank balances on the last day of the fiscal year.
People and assets in 2022
14.1
▲ 0.4 vs 2021
Average over the fiscal year, from the social balance sheet.
€ 940,993
▲ 8% vs 2021
€ 66,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,437
▼ 26% vs 2021
Book value of vehicles, furniture and equipment.
Debts at end 2022
None
No bank loans on the last day of the fiscal year.
€ 111,439
▲ 42% vs 2021
Supplier invoices still open on the last day of the fiscal year.
€ 102,304
▲ 9% vs 2021
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | Change 2021 → 2022 | |
|---|---|---|---|
| Revenue | € 744,736 | - | |
| Gross margin | € 802,862 | € 831,705 | ▲ 4% |
| Profit after taxes | € -320,490 | € -161,909 | ▲ € 158,581 |
| Equity | € 718,194 | € 556,285 | ▼ 23% |
| Total debts | € 175,712 | € 213,743 | ▲ 22% |
| Cash | € 495,200 | € 368,715 | ▼ 26% |
| Land & buildings | € 380,005 | € 341,922 | ▼ 10% |
| Retained profit | € 456,681 | € 294,772 | ▼ 35% |
| Balance sheet total | € 893,906 | € 770,028 | ▼ 14% |
| Employees (FTE) | 13.7 | 14.1 | ▲ 0.4 |
Key figures of Geneeskunde voor het Volk-Genk, fiscal years 2021 to 2022, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2023 has not been filed yet; it was expected before 31 July 2024.
What happened to Geneeskunde voor het Volk-Genk?
What happened at Geneeskunde voor het Volk-Genk in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2022: loss of € 161,909. filed late Source: NBB ↗
- Kim De Witte became a director. NBB
- Wilhelmina Thoolen became a director. NBB
- Willem De Witte became a director. NBB
- New establishment in Genk. KBO
- Stany Nimmegeers became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 320,490 loss in 2021 to € 161,909 loss in 2022.
On average € 59,000 of value added per employee in 2022.
A new publication or filing at Geneeskunde voor het Volk-Genk? We notify you, reason included.
Follow Geneeskunde voor het Volk-GenkDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Geneeskunde voor het Volk-Genk are Kim De Witte, Wilhelmina Thoolen, Willem De Witte and Stany Nimmegeers.
Directors
According to the 2022 annual accounts
Kim De Witte
Director
since 2014
Wilhelmina Thoolen
Director
since 2014
Willem De Witte
Chairman of the board
since 2014
Stany Nimmegeers
Director
since 2005
Establishments
Establishment units
Physical locations of this company
Keinkesstraat 3A
3600 Genk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0418.710.990
- VAT number
- BE 0418.710.990
- Registered office
- Keinkesstraat 3A, 3600 Genk
- Names & denominations
- Geneeskunde voor het Volk-Genk
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 1 June 1978
- Peppol
- Active · Active since 12 Dec 2025
- Activities · NACE
Huisartspraktijken
Medische praktijken
Beroepsopleiding
Promotie en organisatie van scheppende en uitvoerende kunstevenementen
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg